Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways

Tao Lu, Liping Tian, Yulong Han, Michael Vogelbaum, George R. Stark

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Some tumor cell lines secrete high concentrations of TGFβ or IL-1. Similarly high concentrations of each of these cytokines cross-activate the other pathway: TGFβ activates NFκB, and IL-1β activates Smads. The IL-1 signaling components IRAK, MyD88, TRAF6, and TAK1 are all required for cross-activation of NFκB by TGFβ. Knockdown experiments revealed that both TGFβ receptor subunits are required for IL-1β to activate Smads, and the IL-1 receptor is required for TGFβ to activate NFκB. Coimmunoprecipitations showed that either TGFβ or IL-1β stimulate ligand-dependent association of all three receptor subunits. Furthermore, cross-talk between the TGFβ and IL-1 signaling pathways leads to dose-dependent cross-control of gene expression. These interactions provide new insight into biological responses to IL-1 and TGFβ in the proximity of tumors that secrete high concentrations of these factors and probably also at sites of inflammation, where the local concentrations of these cytokines are likely to be high.

Original languageEnglish (US)
Pages (from-to)4365-4370
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume104
Issue number11
DOIs
StatePublished - Mar 13 2007
Externally publishedYes

Fingerprint

Transforming Growth Factors
Interleukin-1
TNF Receptor-Associated Factor 6
Cytokines
Interleukin-1 Receptors
Tumor Cell Line
Ligands
Inflammation
Gene Expression
Neoplasms

Keywords

  • Cytokine receptors
  • NFκB
  • Smad
  • TLRs

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways. / Lu, Tao; Tian, Liping; Han, Yulong; Vogelbaum, Michael; Stark, George R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 11, 13.03.2007, p. 4365-4370.

Research output: Contribution to journalArticle

@article{35fe04b52dde423dbef0a36e22989d7f,
title = "Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways",
abstract = "Some tumor cell lines secrete high concentrations of TGFβ or IL-1. Similarly high concentrations of each of these cytokines cross-activate the other pathway: TGFβ activates NFκB, and IL-1β activates Smads. The IL-1 signaling components IRAK, MyD88, TRAF6, and TAK1 are all required for cross-activation of NFκB by TGFβ. Knockdown experiments revealed that both TGFβ receptor subunits are required for IL-1β to activate Smads, and the IL-1 receptor is required for TGFβ to activate NFκB. Coimmunoprecipitations showed that either TGFβ or IL-1β stimulate ligand-dependent association of all three receptor subunits. Furthermore, cross-talk between the TGFβ and IL-1 signaling pathways leads to dose-dependent cross-control of gene expression. These interactions provide new insight into biological responses to IL-1 and TGFβ in the proximity of tumors that secrete high concentrations of these factors and probably also at sites of inflammation, where the local concentrations of these cytokines are likely to be high.",
keywords = "Cytokine receptors, NFκB, Smad, TLRs",
author = "Tao Lu and Liping Tian and Yulong Han and Michael Vogelbaum and Stark, {George R.}",
year = "2007",
month = "3",
day = "13",
doi = "10.1073/pnas.0700118104",
language = "English (US)",
volume = "104",
pages = "4365--4370",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "11",

}

TY - JOUR

T1 - Dose-dependent cross-talk between the transforming growth factor-β and interleukin-1 signaling pathways

AU - Lu, Tao

AU - Tian, Liping

AU - Han, Yulong

AU - Vogelbaum, Michael

AU - Stark, George R.

PY - 2007/3/13

Y1 - 2007/3/13

N2 - Some tumor cell lines secrete high concentrations of TGFβ or IL-1. Similarly high concentrations of each of these cytokines cross-activate the other pathway: TGFβ activates NFκB, and IL-1β activates Smads. The IL-1 signaling components IRAK, MyD88, TRAF6, and TAK1 are all required for cross-activation of NFκB by TGFβ. Knockdown experiments revealed that both TGFβ receptor subunits are required for IL-1β to activate Smads, and the IL-1 receptor is required for TGFβ to activate NFκB. Coimmunoprecipitations showed that either TGFβ or IL-1β stimulate ligand-dependent association of all three receptor subunits. Furthermore, cross-talk between the TGFβ and IL-1 signaling pathways leads to dose-dependent cross-control of gene expression. These interactions provide new insight into biological responses to IL-1 and TGFβ in the proximity of tumors that secrete high concentrations of these factors and probably also at sites of inflammation, where the local concentrations of these cytokines are likely to be high.

AB - Some tumor cell lines secrete high concentrations of TGFβ or IL-1. Similarly high concentrations of each of these cytokines cross-activate the other pathway: TGFβ activates NFκB, and IL-1β activates Smads. The IL-1 signaling components IRAK, MyD88, TRAF6, and TAK1 are all required for cross-activation of NFκB by TGFβ. Knockdown experiments revealed that both TGFβ receptor subunits are required for IL-1β to activate Smads, and the IL-1 receptor is required for TGFβ to activate NFκB. Coimmunoprecipitations showed that either TGFβ or IL-1β stimulate ligand-dependent association of all three receptor subunits. Furthermore, cross-talk between the TGFβ and IL-1 signaling pathways leads to dose-dependent cross-control of gene expression. These interactions provide new insight into biological responses to IL-1 and TGFβ in the proximity of tumors that secrete high concentrations of these factors and probably also at sites of inflammation, where the local concentrations of these cytokines are likely to be high.

KW - Cytokine receptors

KW - NFκB

KW - Smad

KW - TLRs

UR - http://www.scopus.com/inward/record.url?scp=34248384441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248384441&partnerID=8YFLogxK

U2 - 10.1073/pnas.0700118104

DO - 10.1073/pnas.0700118104

M3 - Article

VL - 104

SP - 4365

EP - 4370

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 11

ER -